A detailed history of Hart & Patterson Financial Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hart & Patterson Financial Group LLC holds 666 shares of LLY stock, worth $598,134. This represents 0.26% of its overall portfolio holdings.

Number of Shares
666
Previous 743 10.36%
Holding current value
$598,134
Previous $433 Million 19.63%
% of portfolio
0.26%
Previous 0.22%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$592.2 - $792.28 $45,599 - $61,005
-77 Reduced 10.36%
666 $518 Million
Q4 2023

Mar 15, 2024

BUY
$525.19 - $619.13 $390,216 - $460,013
743 New
743 $433 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $853B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hart & Patterson Financial Group LLC Portfolio

Follow Hart & Patterson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hart & Patterson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hart & Patterson Financial Group LLC with notifications on news.